Effective Therapies for Diabetes

Dear Colleagues,

Treatment of diabetes, particularly type 2 diabetes, is a growing field. In the last decade, we have gone on an interesting path, from glucocentricity to ever-evolving targeted diabetes therapies aimed at the reduction of chronic complications per se, above all, reducing morbidity and mortality from cardiovascular disorders. In recent years, the protection of target organs, particularly cardiovascular and kidney protection, with antidiabetic drugs have been found to be very important regardless of glycemic control. However, as the field evolves, new questions are emerging, and therefore answers are needed. To answer questions from our daily clinical practice and open new ones, we have created this Special Issue.  

This Special Issue will cover a wide range of topics related to diabetes therapies.

• The effects of antidiabetic drugs on glycemic parameters and beyond;
• Efficacy and safety of new innovative antidiabetic drug formulations;
• Diabetes therapy particularly aimed at reducing chronic diabetic complications;
• The role of antidiabetic therapy in the prevention of macrovascular complications;
• Mechanisms of action of antidiabetic drugs aimed at reducing chronic diabetic complications;
• Drug prescription aspects and approaches in diabetes;
• Treatment of different types of diabetes (beyond type 1 and 2); 
• New and emerging drugs and technologies in diabetes;
• Detection and prevention of hypoglycemia, related to drugs and beyond.

Dr. Miodrag Janić
Dr. Mojca Lunder
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.